Wound Healing Following Tooth Extraction and Ridge Preservation Using DFDBA Alone in Particulate Fiber Form and in Combination With Xenograft
Completed · Not applicable · NCT05400213
Conditions: Dental Extraction, Wound Heal
At a glance
- Research payments reported, 2025
- $20,530
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 102
About the trial
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Tested
- Vallos (DCP) (device), Vallomix (DCF) (device), Vallos-F (DPX) (device), Vallomix-F (DFX) (device)
- Dates
- Started 2022-08-02; completion 2024-12-18
- Results posted
- Yes
The primary aim of the study is to determine the amount of newly formed vital bone, residual graft material, and "connective tissue/other" 18 to 20 weeks after ridge preservation is performed using DFDBA fibers alone, DFDBA particulate alone, a combination of xenograft and DFDBA particulate, or a combination of xenograft and DFDBA fibers.
From ClinicalTrials.gov, last updated 2025-06-19. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Geistlich Pharma, North America, Inc. reported $20,530 in research payments for this study in 2025 (1 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- The University of Texas Health Science Center at San Antonio $20,530
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.